Equator Therapeutics
PrivateLast Round
Grant
Sep 20, 2021
Est. Valuation
$1.79M
Total Funding Raised
$462,400
Company Overview
Equator Therapeutics is a biotechnology company developing a first-in-class drug designed to treat obesity and other metabolic disorders by stimulating mitochondrial thermogenesis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Equator Therapeutics Comparables
Compare Equator Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Incipiam Pharma | 87% | |
| Adipo Therapeutics | 86% | |
| Eolo Pharma | 86% | |
Equator Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 20, 2021 | ||||
| Accelerator | Mar 18, 2020 |
Key People
Founding team and executive leadership
Equator Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| BioGenerator Ventures | VC Round |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| Y Combinator | Accelerator |
| SV Latam Capital | Accelerator |
| Healthspan Capital | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 20, 2021
$1.9M grant awarded by NIH RADx.
- Mar 18, 2020
$125K round led by Y Combinator
Equator Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Equator Therapeutics's valuation, stock price, and market status.